Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation

NCT01798420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2013-02-25

No results posted yet for this study

Summary

Corticosteroid treatment in diabetic patients admitted for COPD exacerbation are expected to significantly increase hemoglobin A1C levels

Conditions

Sponsors & Collaborators

  • The Nazareth Hospital, Israel

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-09-30
Completion
2012-10-31

Countries

  • Israel

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01798420 on ClinicalTrials.gov